- Home
- CGEN vs MIO Comparison
CGEN vs MIO Comparison
Compare CGEN & MIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- MIO
- Stock Information
- Founded
- CGEN 1993
- MIO 2021
- Country
- CGEN Israel
- MIO United States
- Employees
- CGEN N/A
- MIO N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MIO Investment Managers
- Sector
- CGEN Health Care
- MIO Finance
- Exchange
- CGEN Nasdaq
- MIO Nasdaq
- Market Cap
- CGEN 167.4M
- MIO 200.3M
- IPO Year
- CGEN 2000
- MIO N/A
- Fundamental
- Price
- CGEN $1.64
- MIO $11.75
- Analyst Decision
- CGEN
- MIO
- Analyst Count
- CGEN 0
- MIO 0
- Target Price
- CGEN N/A
- MIO N/A
- AVG Volume (30 Days)
- CGEN 264.8K
- MIO 46.0K
- Earning Date
- CGEN 08-05-2025
- MIO 01-01-0001
- Dividend Yield
- CGEN N/A
- MIO 4.57%
- EPS Growth
- CGEN N/A
- MIO N/A
- EPS
- CGEN N/A
- MIO N/A
- Revenue
- CGEN $27,589,000.00
- MIO N/A
- Revenue This Year
- CGEN N/A
- MIO N/A
- Revenue Next Year
- CGEN $173.80
- MIO N/A
- P/E Ratio
- CGEN N/A
- MIO N/A
- Revenue Growth
- CGEN N/A
- MIO N/A
- 52 Week Low
- CGEN $1.13
- MIO $9.18
- 52 Week High
- CGEN $2.66
- MIO $11.36
- Technical
- Relative Strength Index (RSI)
- CGEN 54.29
- MIO 44.37
- Support Level
- CGEN $1.65
- MIO $11.74
- Resistance Level
- CGEN $1.83
- MIO $11.92
- Average True Range (ATR)
- CGEN 0.10
- MIO 0.09
- MACD
- CGEN -0.01
- MIO -0.01
- Stochastic Oscillator
- CGEN 47.50
- MIO 8.70
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About MIO Pioneer Municipal High Income Opportunities Fund Inc.
Pioneer Municipal High Income Opportunities Fund Inc. is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide holders of the Fund's common stock with a high level of current income exempt from regular federal income tax.